Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Serine/threonine-protein kinase mTOR | ||
Ligand | BDBM127374 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Biochemical Assay | ||
pH | 7.5±n/a | ||
Temperature | 298.15±n/a K | ||
Ki | 1.39±n/a nM | ||
Comments | extracted | ||
Citation | Cheng, H; Johnson, TW; Hoffman, JE; Guo, LC; Liu, Z Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions US Patent US8791131 Publication Date 7/29/2014 | ||
More Info.: | Get all data from this article, Assay Method | ||
Serine/threonine-protein kinase mTOR | |||
Name: | Serine/threonine-protein kinase mTOR | ||
Synonyms: | FK506-binding protein 12-rapamycin complex-associated protein 1 | FKBP12-rapamycin complex-associated protein | FRAP | FRAP 1 (mTOR) | FRAP1 | FRAP2 | MTOR | MTOR_HUMAN | Mammalian Target of Rapamycin (mTOR) | P42345 | RAFT1 | RAPT1 | Rapamycin and FKBP12 target 1 | Rapamycin target protein | Serine/threonine-protein kinase (mTOR) | mTORC2 | ||
Type: | Rapamycin target protein | ||
Mol. Mass.: | 288917.12 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P42345 | ||
Residue: | 2549 | ||
Sequence: |
| ||
BDBM127374 | |||
n/a | |||
Name | BDBM127374 | ||
Synonyms: | US8791131, 132 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H21N5O3 | ||
Mol. Mass. | 391.4231 | ||
SMILES | COc1ccc(cn1)-c1ccc2ncc3[nH]c(=O)n([C@H]4CC[C@H](O)CC4)c3c2n1 |r,wU:19.19,wD:22.23,(-6.65,.15,;-5.31,.92,;-3.98,.15,;-3.98,-1.39,;-2.64,-2.16,;-1.31,-1.39,;-1.31,.15,;-2.64,.92,;.02,-2.16,;.02,-3.7,;1.36,-4.47,;2.69,-3.7,;4.02,-4.47,;5.36,-3.7,;5.36,-2.16,;6.5,-1.13,;5.88,.28,;6.65,1.61,;4.34,.12,;3.26,1.2,;1.77,.81,;.68,1.89,;1.08,3.38,;-.01,4.47,;2.56,3.78,;3.65,2.69,;4.02,-1.39,;2.69,-2.16,;1.36,-1.39,)| | ||
Structure |